1. R.E. Black, Epidemiology of diarrhoeal disease: implications for control by vaccines, Vaccine 11 (1993), pp. 100–106.
2. J.R. Thiagarajah and A.S. Verkman, New drug targets for cholera therapy, Trends Pharmacol. Sci. 26 (2005), pp. 172–175.
3. D.A. Sack, R.B. Sack, G.B. Nair and A.K. Siddique, Cholera, Lancet 363 (2004), pp. 223–233.
4. World Health Organization, Cholera, Wkly. Epidemiol. Rec. 78 (2003), pp. 269–276.
5. United Nations. 1993. Convention on the prohibition of the development, production, stockpiling and use of chemical weapons and on their destruction. Paris, France.
6. R.G. Zhang, M.L. Westbrook, E.M. Westbrook, D.L. Scott, Z. Otwinowski, P.R. Maulik, R.A. Reed and G.G. Shipley, The 2.4 Å crystal structure of cholera toxin B subunit pentamer: choleragenoid, J. Mol. Biol. 251 (1995), pp. 550–562.
7. R.G. Zhang, D.L. Scott, M.L. Westbrook, S. Nance, B.D. Spangler, G.G. Shipley and E.M. Westbrook, The three-dimensional crystal structure of cholera toxin, J. Mol. Biol. 251 (1995), pp. 563–573.
8. E.A. Merritt, P. Kuhn, S. Sarfaty, J.L. Erbe, R.K. Holmes and W.G. Hol, The 1.25 Å resolution refinement of the cholera toxin B-pentamer: evidence of peptide backbone strain at the receptor-binding site, J. Mol. Biol. 282 (1998), pp. 1043–1059.
9. L. De Haan and T.R. Hirst, Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms (Review), Mol. Membr. Biol. 21 (2004), pp. 77–92.
10. G.W. Sharp and S. Hynie, Stimulation of intestinal adenyl cyclase by cholera toxin, Nature 229 (1971), pp. 266–269.
11. R.L. Guerrant, L.C. Chen and G.W. Sharp, Intestinal adenyl-cyclase activity in canine cholera: correlation with fluid accumulation, J. Infect. Dis. 125 (1972), pp. 377–381.
12. G.L. Johnson, H.R. Kaslow and H.R. Bourne, Genetic evidence that cholera toxin substrates are regulatory components of adenylate cyclase, J. Biol. Chem. 253 (1978), pp. 7120–7123.
13. M. Field, D. Fromm, Q. al-Awqati and W.B. Greenough, Effect of cholera enterotoxin on ion transport across isolated ileal mucosa, J. Clin. Invest 51 (1972), pp. 796–804.
14. D.E. Schafer, W.D. Lust, J.B. Polson, J. Hedtke, B. Sircar, A.K. Thakur and N.D. Goldberg, The possible role of cyclic AMP in some actions of cholera toxin, Ann. N. Y. Acad. Sci. 185 (1971), pp. 376–385.
15. D.E. Schafer, W.D. Lust, B. Sircar and N.D. Goldberg, Elevated concentration of adenosine 3′:5′-cyclic monophosphate in intestinal mucosa after treatment with cholera toxin, Proc. Natl. Acad. Sci. USA 67 (1970), pp. 851–856.
16. M. Field, M.C. Rao and E.B. Chang, Intestinal electrolyte transport and diarrheal disease (2), N. Engl. J. Med. 321 (1989), pp. 879–883.
17. S.H. Cheng, D.P. Rich, J. Marshall, R.J. Gregory, M.J. Welsh and A.E. Smith, Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel, Cell 66 (1991), pp. 1027–1036.
18. R.M. Burch, C. Jelsema and J. Axelrod, Cholera toxin and pertussis toxin stimulate prostaglandin E2 synthesis in a murine macrophage cell line, J. Pharmacol. Exp. Ther. 244 (1988), pp. 765–773.
19. S.V. Heyningen, Cholera toxin: interaction of subunits with ganglioside GM1, Science 183 (1974), pp. 656–657.
20. S.L. Griffiths, R.A. Finkelstein and D.R. Critchley, Characterization of the receptor for cholera toxin and Escherichia coli heat-labile toxin in rabbit intestinal brush borders, Biochem. J. 238 (1986), pp. 313–322.
21. C.L. Schengrund and N.J. Ringler, Binding of Vibrio cholera toxin and the heat-labile enterotoxin of Escherichia coli to GM1, derivatives of GM1, and nonlipid oligosaccharide polyvalent ligands, J. Biol. Chem. 264 (1989), pp. 13233–13237.
22. D.C. Smith, J.M. Lord, L.M. Roberts and L. Johannes, Glycosphingolipids as toxin receptors, Semin. Cell Dev. Biol. 15 (2004), pp. 397–408.
23. K. Sandvig, B. Spilsberg, S.U. Lauvrak, M.L. Torgersen, T.G. Iversen and B. van Deurs, Pathways followed by protein toxins into cells, Int. J. Med. Microbiol. 293 (2004), pp. 483–490.
24. R.H. Massol, J.E. Larsen, Y. Fujinaga, W.I. Lencer and T. Kirchhausen, Cholera toxin toxicity does not require functional Arf6- and dynamin-dependent endocytic pathways, Mol. Biol. Cell 15 (2004), pp. 3631–3641.
25. W.I. Lencer, Retrograde transport of cholera toxin into the ER of host cells, Int. J. Med. Microbiol. 293 (2004), pp. 491–494.
26. Y. Feng, A.P. Jadhav, C. Rodighiero, Y. Fujinaga, T. Kirchhausen and W.I. Lencer, Retrograde transport of cholera toxin from the plasma membrane to the endoplasmic reticulum requires the trans-Golgi network but not the Golgi apparatus in Exo2-treated cells, EMBO Rep. 5 (2004), pp. 596–601.
27. W.I. Lencer and B. Tsai, The intracellular voyage of cholera toxin: going retro, Trends Biochem. Sci. 28 (2003), pp. 639–645.
28. Y. Fujinaga, A.A. Wolf, C. Rodighiero, H. Wheeler, B. Tsai, L. Allen, M.G. Jobling, T. Rapoport, R.K. Holmes and W.I. Lencer, Gangliosides that associate with lipid rafts mediate transport of cholera and related toxins from the plasma membrane to endoplasmic reticulum, Mol. Biol. Cell 14 (2003), pp. 4783–4793.
29. K. Teter, M.G. Jobling and R.K. Holmes, A class of mutant CHO cells resistant to cholera toxin rapidly degrades the catalytic polypeptide of cholera toxin and exhibits increased endoplasmic reticulum-associated degradation, Traffic 4 (2003), pp. 232–242.
30. B. Tsai, C. Rodighiero, W.I. Lencer and T.A. Rapoport, Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin, Cell 104 (2001), pp. 937–948.
31. B. Tsai and T.A. Rapoport, Unfolded cholera toxin is transferred to the ER membrane and released from protein disulfide isomerase upon oxidation by Ero1, J. Cell Biol. 159 (2002), pp. 207–216.
32. B. Tsai, Y. Ye and T.A. Rapoport, Retro-translocation of proteins from the endoplasmic reticulum into the cytosol, Nat. Rev. Mol. Cell Biol. 3 (2002), pp. 246–255.
33. T.R. Hirst, S. Fraser, M. Soriani, A.T. Aman, H.L. de Haan, A. Hearn and E. Merritt, New insights into the structure-function relationships and therapeutic applications of cholera-like enterotoxins, Int. J. Med. Microbiol. 291 (2002), pp. 531–535.
34. T. Takao, H. Watanabe and Y. Shimonishi, Facile identification of protein sequences by mass spectrometry. B subunit of Vibrio cholerae classical biotype Inaba 569B toxin, Eur. J. Biochem. 146 (1985), pp. 503–508.
35. B.L. van Baar, A.G. Hulst and E.R. Wils, Characterisation of cholera toxin by liquid chromatography—electrospray mass spectrometry, Toxicon 37 (1999), pp. 85–108.
36. E.N. Kitova, P.I. Kitov, D.R. Bundle and J.S. Klassen, The observation of multivalent complexes of Shiga-like toxin with globotriaoside and the determination of their stoichiometry by nanoelectrospray Fourier-transform ion cyclotron resonance mass spectrometry, Glycobiology 11 (2001), pp. 605–611.
37. J.P. Williams, B.N. Green, D.C. Smith, K.R. Jennings, K.A. Moore, S.E. Slade, L.M. Roberts and J.H. Scrivens, Noncovalent Shiga-like toxin assemblies: characterization by means of mass spectrometry and tandem mass spectrometry, Biochemistry 44 (2005), pp. 8282–8290.
38. N. Felitsyn, E.N. Kitova and J.S. Klassen, Thermal decomposition of a gaseous multiprotein complex studied by blackbody infrared radiative dissociation. Investigating the origin of the asymmetric dissociation behavior, Anal. Chem. 73 (2001), pp. 4647–4661.
39. H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov and P.E. Bourne, The protein data bank, Nucleic Acids Res. 28 (2000), pp. 235–242.
40. R.A. Abagyan, M.M. Totrov and D.A. Kuznetsov, ICM—a new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation, J. Comput. Chem. 15 (1994), pp. 488–506.
41. C. Jemal, J.E. Haddad, D. Begum and M.P. Jackson, Analysis of Shiga toxin subunit association by using hybrid A polypeptides and site-specific mutagenesis, J. Bacteriol. 177 (1995), pp. 3128–3132.
42. M.E. Fraser, M.M. Chernaia, Y.V. Kozlov and M.N. James, Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 Å resolution, Nat. Struct. Biol. 1 (1994), pp. 59–64.
43. S.U. van Heyningen, Conformational changes in subunit A of cholera toxin following the binding of ganglioside to subunit B, Eur. J. Biochem. 122 (1982), pp. 333–337.
44. B. Goins and E. Freire, Thermal stability and intersubunit interactions of cholera toxin in solution and in association with its cell-surface receptor ganglioside GM1, Biochemistry 27 (1988), pp. 2046–2052.
45. W.K. Surewicz, J.J. Leddy and H.H. Mantsch, Structure, stability, and receptor interaction of cholera toxin as studied by Fourier-transform infrared spectroscopy, Biochemistry 29 (1990), pp. 8106–8111.
46. D.G. Pina and L. Johannes, Cholera and Shiga toxin B-subunits: thermodynamic and structural considerations for function and biomedical applications, Toxicon 45 (2005), pp. 389–393.
47. J.A. McCann, J.A. Mertz, J. Czworkowski and W.D. Picking, Conformational changes in cholera toxin B subunit-ganglioside GM1 complexes are elicited by environmental pH and evoke changes in membrane structure, Biochemistry 36 (1997), pp. 9169–9178.
48. W.L. Picking, H. Moon, H. Wu and W.D. Picking, Fluorescence analysis of the interaction between ganglioside GM1-containing phospholipid vesicles and the B subunit of cholera toxin, Biochim. Biophys. Acta 1247 (1995), pp. 65–73.
49. D.G. Pina, J. Gomez, E. Villar, L. Johannes and V.L. Shnyrov, Thermodynamic analysis of the structural stability of the Shiga toxin B-subunit, Biochemistry 42 (2003), pp. 9498–9506.
50. T.K. Sixma, P.E. Stein, W.G. Hol and R.J. Read, Comparison of the B-pentamers of heat-labile enterotoxin and verotoxin-1: two structures with remarkable similarity and dissimilarity, Biochemistry 32 (1993), pp. 191–198.
51. P.E. Stein, A. Boodhoo, G.J. Tyrrell, J.L. Brunton and R.J. Read, Crystal structure of the cell-binding B oligomer of verotoxin-1 from, E. coli. Nature 355 (1992), pp. 748–750.